2021
DOI: 10.1111/vox.13208
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Sysmex XN‐31 automated analyser for blood donor malaria screening at Malawi Blood Transfusion Services

Abstract: Background and Objectives Balancing blood supply safety and sufficiency is challenging in malaria‐endemic countries where the risk of transfusion‐transmitted malaria (TTM) is ever‐present. In support of reducing this risk, our study aimed at evaluating the performance of the Sysmex XN‐31 analyser in blood donor malaria screening, as compared with current practice in Malawi. Materials and Methods This prospective observational study was conducted on remnant venous donor blood samples collected at Malawi Blood T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 25 publications
1
9
0
Order By: Relevance
“…In one study from Cameroon, it was found that 2 out of every 10 sickle cell patients who died had malaria [ 26 ]. To date, there have been preliminary studies done how interferences affect the results of the XN-31, but there is some discrepancy in the results and what conditions can trigger an abnormal scattergram on the XN-31 [ 14 , 15 ]. For the investigation of RBC abnormalities, abnormal samples were deliberately collected to determine the effect on the XN-31 result.…”
Section: Discussionmentioning
confidence: 99%
“…In one study from Cameroon, it was found that 2 out of every 10 sickle cell patients who died had malaria [ 26 ]. To date, there have been preliminary studies done how interferences affect the results of the XN-31, but there is some discrepancy in the results and what conditions can trigger an abnormal scattergram on the XN-31 [ 14 , 15 ]. For the investigation of RBC abnormalities, abnormal samples were deliberately collected to determine the effect on the XN-31 result.…”
Section: Discussionmentioning
confidence: 99%
“…26 To date, there have been preliminary studies done how interferences affect the results of the XN-31, but there is some discrepancy in the results and what conditions can trigger an abnormal scattergram on the XN-31. 14,15 Further need to be done in order to determine whether the XN-31 can properly detect Plasmodium infected RBC in patients with sickle cell disease and other diseases that significantly affect red blood cell morphology and/or erythropoiesis.…”
Section: Discussionmentioning
confidence: 99%
“…Using fluorescence flow cytometry (FFC) technology and a violet semiconductor laser with a 405 nm wavelength, this hemocytometer can detect, specify and quantitate malaria-infected red blood cells (MI-RBC) within a specific area of the scattergram known as the M-gating area. Previous studies on the XN-31 and its predecessor the XN-30 reported mainly data on P. falciparum infected patients in endemic countries [12][13][14][15][16] or on in vitro cultures 13,17,18 . The XN-30, was approved for research purposes only, whereas the XN-31 is a CE marked in vitro diagnostic device with identical hardware, software, and user interface.…”
Section: Introductionmentioning
confidence: 99%
“…This study is a secondary data analysis of a prior study [ 9 ] that was undertaken to establish the usefulness of XN-31 for malaria screening in a malaria-endemic setting and to establish the true prevalence of malaria parasitaemia amongst blood donors in Malawi. The primary study was a prospective observational study that used residual venous blood samples from donors at MBTS donation sites countrywide for routine blood-borne pathogen screening.…”
Section: Methodsmentioning
confidence: 99%